BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-25 Cr | ₹-24 Cr | ₹-21 Cr | ₹-6.30 Cr | ₹17 Cr |
What is the latest Cash Flow from Financing Activities ratio of BLISS GVS PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-25 Cr |
Mar2022 | ₹-24 Cr |
Mar2021 | ₹-21 Cr |
Mar2020 | ₹-6.30 Cr |
Mar2019 | ₹17 Cr |
How is Cash Flow from Financing Activities of BLISS GVS PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-25 Cr | Negative | |
Mar2022 | ₹-24 Cr | Negative | |
Mar2021 | ₹-21 Cr | Negative | |
Mar2020 | ₹-6.30 Cr | Negative | |
Mar2019 | ₹17 Cr | - |
Compare Cash Flow from Financing Activities of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,352.7 Cr | 10.7% | 14.7% | 61.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | 10.7% |
14.7% |
61.2% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses